Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer

Published:2020-11-12 Issue:11 Volume:6 Page:e204429
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Blayney Douglas W.¹,Zhang Qingyuan²,Feng Jifeng³,Zhao Yanqiu⁴,Bondarenko Igor⁵,Vynnychenko Ihor⁶,Kovalenko Nadezhda⁷,Nair Santosh⁸,Ibrahim Emad⁹,Udovista Dmitriy Petrovich¹⁰,Mohanlal Ramon¹¹,Ogenstad Stephan¹²,Ette Ene¹³,Du Lihua¹⁴,Huang Lan¹¹,Shi Yuan-kai¹⁵¹⁶

Affiliation:

1. Stanford Cancer Institute, Stanford, California

2. Harbin Medical University Cancer Hospital, Harbin, China

3. Department of Medical Oncology, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China

4. Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

5. Dnipropetrovsk Medical Academy, Ukraine. Dnepropetrovsk, Ukraine

6. Sumy Regional Clinical Oncology Dispensary, Sumy State University, Sumy, Ukraine

7. Volgograd Regional Clinical Oncology Dispensary, Volgograd, Russia

8. Mid Florida Hematology and Oncology Center, Orange City

9. Redlands Community Hospital, Redlands, California

10. SBI of Healthcare Oncology Dispensary No. 2, Ministry of Health of Krasnodar Region, Sochi, Russia

11. BeyondSpring Pharmaceuticals, New York, New York

12. Statogen Consulting, Wake Forest, North Carolina

13. Anoixis Corporation, Natick, Massachusetts

14. Wanchun Bulin Pharmaceuticals Limited, Dalian, China

15. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

16. Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2770700/jamaoncology_blayney_2020_oi_200070_1604947267.93225.pdf

Reference26 articles.

1. Management of fever in patients with cancer and treatment-induced neutropenia.;Pizzo;N Engl J Med,1993

2. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.;Crawford;N Engl J Med,1991

3. Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.;Holmes;Ann Oncol,2002

4. Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy.;Blackwell;Ann Oncol,2015